The Medical AI Podcast Episode 54: Can AI Transform Drug Development? With Dr Scott Chetham, CEO of Faro Health
7 snips
Mar 15, 2025 Dr. Scott Chetham, a clinical scientist and CEO of Faro Health, brings over 20 years of experience in clinical trials to the discussion. He dives into the costly failures of drug development, highlighting that 90% of candidates never see approval. Scott explains how AI can revolutionize this process by targeting the right data and patients, potentially saving millions and speeding up development times. He also discusses Faro's innovative platform for improving trial design and its broader implications for public health.
AI Snips
Chapters
Transcript
Episode notes
Focus On Time-Saving Automation
- Compress trial timelines by automating repetitive high-value tasks to cut costs driven mainly by time.
- Target many small time improvements across the process to achieve large cumulative savings.
Sabbatical Sparked Faro Health
- Scott recounts leaving Google X and surfing in Costa Rica to conceive his company, Faro, inspired by a lighthouse named 'Faro'.
- That sabbatical clarified his mission to redesign how trials are planned and run.
Benchmarking Reveals Hidden Trial Burdens
- Faro benchmarks thousands of past trials to show designers patient burden, site burden, and likely failure points before launch.
- This data-driven view forces teams to ask whether patients and hospitals can actually deliver the protocol.